Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach

Area of Science:

• Cardiology
• Electrophysiology
• Genetics

Background:

• Sudden cardiac death (SCD) is a major risk in non-ischaemic dilated cardiomyopathy (NIDCM).
• Implantable cardioverter-defibrillators (ICDs) can prevent SCD, but identifying high-risk NIDCM patients for primary prevention is challenging.
• Current guidelines for ICD implantation in NIDCM may not optimize longevity for all patients.

Purpose of the Study:

• To review current guidelines for ICD therapy in NIDCM.
• To explore established and novel predictors of SCD in NIDCM patients.
• To identify strategies for personalized ICD therapy selection.

Main Methods:

• Review of current international guidelines for primary prevention ICD therapy.
• Evaluation of established predictors of SCD in NIDCM.
• Exploration of novel multi-parametric predictors (myocardial, electrical, serological, genetic).

Main Results:

• Current guidelines for primary prevention ICDs in NIDCM with severe left ventricular dysfunction do not consistently improve longevity.
• More precise risk stratification methods are needed to identify NIDCM patients who truly benefit from ICD therapy.
• Multi-parametric assessment of substrate offers novel strategies for predicting major arrhythmic risk.

Conclusions:

• Personalized therapy selection in NIDCM is crucial to maximize benefits and avoid unnecessary ICD implantation.
• Novel predictive strategies are needed to better identify NIDCM patients at high risk for SCD.
• Balancing SCD risk with the risk of non-sudden death is essential for optimizing patient outcomes.